The Bull Rankings scorecard — our quality-growth score is 52.2 / 100, built from three pillars scored 0–100: Quality 59, Growth 41, Value 59 (valuation is judged against sector peers). At today's price, our reverse-DCF read says the market is implicitly betting on free-cash-flow growth of about 10% a year next year, fading to 3% a year by year ten — a gauge of how much optimism is already in the stock.
The thesis
Nutrien’s current price of $80.72 sits a little above the analyst consensus target of $76.43 and within the $59–$90 range, yet it still trades at a modest P/E of 16.3. That valuation, combined with a free‑cash‑flow of $2.1 b and a debt‑to‑equity of 0.49, signals a company that is neither over‑leveraged nor over‑valued. Our model’s Quality‑growth score of 52.2/100 is anchored by a Quality pillar of 59, tied with Value as the highest of the three. The Growth pillar of 41 is the weakest, reflecting the modest 3.5 % revenue growth YoY. Still, the quality signals—an ROE of 9.1 % and a profit margin of 8.5 %—suggest a steady, cash‑generating enterprise. The thesis is simple: Nutrien looks reasonably priced on multiples, but the price already assumes faster cash‑flow growth than its revenue is delivering.
What the business actually is
Nutrien’s revenue engine is split across four segments. The Retail segment sells crop nutrients, crop protection products, seed, and merchandise, and offers agronomic application and financing services. Proprietary crop nutrient, crop protection, and seed products give it a differentiated product mix. The Potash segment mines and processes potash, a key fertilizer mineral. The Nitrogen segment owns ammonia production facilities that supply ammonia, urea, ammonium nitrate (UAN), urea solutions, nitric acid, and ammonium nitrate, positioning Nutrien as a full‑spectrum nitrogen provider. Finally, the Phosphate segment produces phosphate fertilizers and industrial products. Together, these segments create a vertically integrated supply chain that serves farmers worldwide.
Why it can (or can't) keep compounding
Nutrien’s moat is built on scale and integration. With a debt‑to‑equity of 0.49, the company can finance expansion without diluting shareholders. Its profit margin of 8.5 % is healthy for a commodity‑heavy business, and the ROE of 9.1 % indicates adequate returns on capital. The Retail segment’s proprietary products and agronomic services create switching costs for farmers, while the Potash and Nitrogen segments lock in supply chains that are capital‑intensive to replicate. Competitors would need to match Nutrien’s combined mining, processing, and distribution network—a costly, time‑consuming endeavor. Thus, the company is positioned to compound earnings as it expands market share in each segment.
The valuation question
The reverse‑DCF implied growth of ~10 % per year (in year one, slowing to 3% a year by year ten) is a generous assumption. Compared to the 3.5 % revenue growth reported for FY YoY, the market is pricing in a significant upside. The P/E of 16.3 is below the sector average, and the PEG ratio of 1.35 says the multiple runs somewhat ahead of the earnings growth analysts expect. If the company can sustain the implied 10 % FCF growth, the current price is justified. Conversely, if revenue growth stalls, the valuation would look too high. The key is whether Nutrien can translate its quality into accelerated revenue and FCF growth.
The bear case
The weakest pillar in our model is Growth (41), reflecting the modest 3.5 % revenue growth. If the company fails to lift revenue beyond this level, the implied 10 % FCF growth becomes unrealistic. A concrete signal would be a decline in the profit margin below 8.5 %, indicating cost pressures or commodity price volatility. Such a scenario would erode free cash flow and undermine the valuation premise.
What would change our mind
- Revenue growth falling below 3.5 % for two consecutive quarters would weaken the growth narrative.
- Profit margin slipping below 8.5 % would signal deteriorating cost control.
- Debt‑to‑equity rising above 0.49 would raise leverage concerns and limit expansion capacity.
If any of these thresholds are breached, the current upside premise would collapse, and the thesis would shift to a more cautious stance.